Subclinical organ damage and cardiovascular risk prediction

References

• Magnus P, Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: Time to end the “only-50%” myth. Arch Intern Med. 2001;161:2657–2660.
   PubMedGoogle Scholar
• Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, . Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282: 2012–2018.
   PubMed Web of Science ®Google Scholar
• Law MR, Wald NJ, Morris JK. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke. J Med Screen. 2004;11:3–7.
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, . 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–1187.
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, . Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens. 2009 Oct 15.
   Web of Science ®Google Scholar
• Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, . Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens. 2009;27:2458–2464.
   PubMed Web of Science ®Google Scholar
• Woythaler JN, Singer SL, Kwan OL, Meltzer RS, Reubner B, Bommer W, . Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: Comparison with postmortem mass measurements. J Am Coll Cardiol. 1983;2:305–11.
   PubMed Web of Science ®Google Scholar
• Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: Reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension. 2002;40:673–678.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, . The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. J Hypertens. 2009;27:1697–1704.
   PubMed Web of Science ®Google Scholar
• Li Z, Dahlof B, Okin PM, Kjeldsen SE, Wachtell K, Ibsen H, . Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension study. J Hypertens. 2008;26: 1244–1249.
   PubMed Web of Science ®Google Scholar
• Schillaci G, Pirro M, Ronti T, Gemelli F, Pucci G, Innocente S, . Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med. 2006;166:909–13.
   PubMedGoogle Scholar
• Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, . Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: The Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE). Circulation. 2009;119: 1883–1891.
   PubMed Web of Science ®Google Scholar
• Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, . Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol. 2008;41:342–350.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Cuspidi C, Comarella L, Rosei EA, Ambrosioni E, Chiariello M, . Left ventricular diastolic dysfunction in elderly hypertensives: Results of the APROS-diadys study. J Hypertens. 2007;25:2158–2167.
   PubMed Web of Science ®Google Scholar
• Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, . Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens. 2005;23:183–91.
   PubMed Web of Science ®Google Scholar
• Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001;103:2346–2351.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: The Strong Heart Study. Hypertension. 2004;43:769–774.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115:459–467.
   PubMed Web of Science ®Google Scholar
• Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Lochen ML, . Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromso Study. Stroke. 2007;38:2873–2880.
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Labreuche J, Vicaut E, Amarenco P. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke. 2005;36: 1741–1745.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, . Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: Findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation. 2009;120:1084–1090.
   PubMed Web of Science ®Google Scholar
• Johnsen SH, Mathiesen EB. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep. 2009;11:21–27.
   PubMedGoogle Scholar
• Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: A tool for rapid evaluation of new therapies. Stroke. 2005;36:1904–1909.
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van BL, Boutouyrie P, Giannattasio C, Hayoz D, . Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605.
   PubMed Web of Science ®Google Scholar
• Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, . Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA. 2008;300:197–208.
   PubMed Web of Science ®Google Scholar
• Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, . Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345.
   PubMed Web of Science ®Google Scholar
• Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39(2, Supplement 1): S46–S75.
   Google Scholar
• Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, . Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315.
   PubMed Web of Science ®Google Scholar
• Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, . Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62:1402–1407.
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, . Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100.
   PubMed Web of Science ®Google Scholar
• Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis. 2004;44:84–93.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
   PubMed Web of Science ®Google Scholar
• Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, . Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens. 2007;25:1473–1479.
   PubMed Web of Science ®Google Scholar
• Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791–1798.
   PubMed Web of Science ®Google Scholar
• Cirillo M, Lanti MP, Menotti A, Laurenzi M, Mancini M, Zanchetti A, . Definition of kidney dysfunction as a cardiovascular risk factor: Use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med. 2008;168:617–624.
   PubMedGoogle Scholar
• Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlof B, Devereux RB, . Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: The LIFE study. J Hypertens. 2006;24:775–781.
   PubMed Web of Science ®Google Scholar
• Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35: 898–903.
   PubMed Web of Science ®Google Scholar
• Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–935.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG, . Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003;24:987–1003.
   PubMed Web of Science ®Google Scholar
• Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, . Risk stratification with the risk chart from the European Society of Hypertension compared with SCORE in the general population. J Hypertens. 2009;27:2351–2357.
   PubMed Web of Science ®Google Scholar
• Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Petersen C, . Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2009;Dec 23.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, . Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168: 1333–1339.
   PubMed Web of Science ®Google Scholar
• Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H, . Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? J Hypertens. 2009;27:1165–1171.
   PubMed Web of Science ®Google Scholar
• Diamond GA, Kaul S. The things to come of SHAPE: Cost and effectiveness of cardiovascular prevention. Am J Cardiol. 2007;99:1013–1015.
   PubMed Web of Science ®Google Scholar
• Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, . From vulnerable plaque to vulnerable patient–Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H–15H.
   PubMed Web of Science ®Google Scholar
• Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G. The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: Systematic review. Health Technol Assess. 2006;10:iii–x, 1.
   Google Scholar
• Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, . ACCF/AHA. 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the. 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007;115:402–426.
   PubMed Web of Science ®Google Scholar
• Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, . Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:496–507.
   PubMed Web of Science ®Google Scholar
• Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, . Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45:198–202.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, . Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, . Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343–2349.
   PubMed Web of Science ®Google Scholar
• O'Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: A randomized controlled trial. JAMA. 2003;289: 2215–2223.
   PubMed Web of Science ®Google Scholar
• Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394–399.
   PubMed Web of Science ®Google Scholar
• Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, . Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008; 101:999–1002.
   PubMed Web of Science ®Google Scholar